ACST logo

Acasti Pharma (ACST) Company Overview

Profile

Full Name:

Grace Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 7, 2012

Indexes:

Not included

Description:

Acasti Pharma is a biopharmaceutical company focused on developing innovative treatments for cardiovascular diseases. They specialize in drug development using omega-3 fatty acids to improve heart health. Their main product, CaPre, aims to reduce triglyceride levels in patients with high cholesterol.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Jun 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 10, 2023

Analyst ratings

Recent major analysts updates

Nov 25, 20 Oppenheimer
Outperform
Nov 25, 20 H.C. Wainwright
Buy
Nov 25, 20 Benchmark
Speculative Buy
Nov 25, 20 B. Riley FBR
Buy
Nov 25, 20 Aegis Capital
Buy
Sep 2, 20 Aegis Capital
Hold
Sep 1, 20 Oppenheimer
Perform
Sep 1, 20 B. Riley FBR
Neutral
Jul 6, 20 B. Riley FBR
Buy
May 6, 20 Aegis Capital
Buy

Screeners with ACST included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for Acasti Pharma?
  • Does Acasti Pharma pay dividends?
  • What sector is Acasti Pharma in?
  • What industry is Acasti Pharma in?
  • What country is Acasti Pharma based in?
  • When did Acasti Pharma go public?
  • Is Acasti Pharma in the S&P 500?
  • Is Acasti Pharma in the NASDAQ 100?
  • Is Acasti Pharma in the Dow Jones?
  • When was Acasti Pharma's last earnings report?
  • When does Acasti Pharma report earnings?
  • Should I buy Acasti Pharma stock now?

What is the ticker symbol for Acasti Pharma?

The ticker symbol for Acasti Pharma is NASDAQ:ACST

Does Acasti Pharma pay dividends?

No, Acasti Pharma does not pay dividends

What sector is Acasti Pharma in?

Acasti Pharma is in the Healthcare sector

What industry is Acasti Pharma in?

Acasti Pharma is in the Biotechnology industry

What country is Acasti Pharma based in?

Acasti Pharma is headquartered in United States

When did Acasti Pharma go public?

Acasti Pharma's initial public offering (IPO) was on February 7, 2012

Is Acasti Pharma in the S&P 500?

No, Acasti Pharma is not included in the S&P 500 index

Is Acasti Pharma in the NASDAQ 100?

No, Acasti Pharma is not included in the NASDAQ 100 index

Is Acasti Pharma in the Dow Jones?

No, Acasti Pharma is not included in the Dow Jones index

When was Acasti Pharma's last earnings report?

Acasti Pharma's most recent earnings report was on Nov 13, 2024

When does Acasti Pharma report earnings?

The date for Acasti Pharma's next earnings report has not been announced yet

Should I buy Acasti Pharma stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions